Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

XPH

SPDR Pharmaceuticals ETF

Dec 24 • 04:00PM ET

43.41

Dollar change 0.00
Percentage change 0.00	%

Financial • Exchange Traded Fund • USA • NYSE

Held by: MSSS

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	7.13%	Shs Outstand		Perf Week	-2.80%
Sponsor	State Street (SPDR)	ETF Type		Tags	equity	Return% 3Y	-0.38%	Total Holdings	46	Perf Month	-6.79%
Fund Family		Bond Type		Tags	pharmaceutical	Return% 5Y	0.29%	AUM	156.58M	Perf Quarter	-0.32%
Index	S&P Pharmaceuticals Sel Industry Indx	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	8.38%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	5.83%
Active/Passive		Quant Type		Tags	-	Flows% 1M	1.39%	52W Range	38.88 - 48.76	Perf YTD	4.30%
Dividend TTM	0.68 (1.56%)	ESG Type		Tags	-	Flows% 3M	-14.75%	52W High	-10.97%	Beta	0.72
Dividend Ex-Date	Dec 23, 2024	Dividend Type		Sector/Theme		Flows% YTD	-32.41%	52W Low	11.65%	ATR (14)	0.69
Expense	0.35%	Structure Type		Region		Flows% 1Y		RSI (14)	34.73	Volatility	2.05% 1.33%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	1.41	Prev Close	43.41
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	62.47K	Price	43.41
SMA20	-3.42%	SMA50	-5.35%	SMA200	1.14%	Trades		Volume	86,594	Change	0.00%

Jun-17-21 11:00AM	Supreme Court upholds Obamacare in latest ruling (Yahoo Finance Video)
Oct-14-20 09:01AM	Pharma Stocks Poised to Move Higher (Investopedia)
Aug-11-20 03:29PM	Best Pharmaceutical ETFs for Q4 2020 (Investopedia)
Jun-04-20 01:00PM	5 Sector ETFs Just Got Upgraded to Buy (Zacks)
May-22-20 07:46AM	Telehealth is going to 'become the default' for patients: Ro CEO (Yahoo Finance)
11:05AM	Loading…
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Jan-15-20 01:55PM	Mallinckrodt's stocks soars on heavy volume toward near-40% gain this week after comments at broker conference (MarketWatch)
Jan-13-20 01:31PM	Top Pharmaceutical Stocks for Q1 2020 (Investopedia)
Jan-08-20 11:12AM	A Look at the S&P Sectors from 2019 (ETF Trends)
Dec-27-19 02:19PM	Biotech Rally Sends Nasdaq to 9000: ETFs in Focus (Zacks)
Dec-26-19 02:30PM	4 Sector ETFs That Beat the Market in Q4 (Zacks)
Nov-08-19 08:00AM	Pharma Sector Tops in October: Best ETFs & Stocks (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
Oct-30-19 10:43AM	Healthcare ETFs Win in October: Here's Why (Zacks)
Oct-26-19 06:00AM	Mercks Earnings Are on Tuesday. Heres What to Expect. (Barrons.com)
12:21PM	Loading…
Oct-15-19 12:21PM	AbbVie, Bristol-Myers Squibb Getting the Most From Workers (GuruFocus.com)
Oct-13-19 05:15PM	New Sanofi CEO Looks to Shake Things Up (GuruFocus.com)
Aug-27-19 04:11PM	Stock market news: August 27, 2019 (Yahoo Finance)
Aug-22-19 11:12AM	8 ETFs to Capture Opportunities in Healthcare Sector (ETF Trends)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
Jul-14-19 11:00AM	4 Hot Pharmaceutical ETFs (ETF Trends)
Jul-09-19 05:39PM	Why disclosing drug prices in TV ads won't lower costs (Yahoo Finance)
Jul-08-19 10:42AM	Health stocks under pressure in wake of Trump plan to issue executive order on drug pricing (MarketWatch)
Jul-05-19 04:22PM	Stocks end slightly lower after strong jobs report puts Fed rate cuts in question (MarketWatch)
01:43PM	Trump Today: President leans on Fed anew and mulls census executive order (MarketWatch)
Jun-26-19 11:00AM	AbbVie to Buy Allergan: Prescribed ETFs (Zacks)
Jun-25-19 06:01PM	AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs (ETF Trends)
07:42AM	Drug maker stocks rally after AbbVie's deal to buy Allergan for 45% premium (MarketWatch)
Jun-17-19 04:01PM	FDA approves non-insulin Type 2 diabetes drug for kids, the first to hit market in 20 years (MarketWatch)
Jun-10-19 07:51AM	Insys files for bankruptcy, stock plunges toward record low (MarketWatch)
05:40PM	Loading…
May-14-19 05:40PM	Legal Troubles Beset Pharmaceutical Sector ETFs (ETF Trends)
May-13-19 02:59PM	Stocks of generic drug companies fall after more than 40 states file suit alleging price fixing (MarketWatch)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
May-02-19 02:28PM	Declining sales of blockbuster drug drag Teva revenue lower (MarketWatch)
Apr-23-19 03:11PM	3 Healthcare ETFs to Sell Amid Political Headwinds (InvestorPlace)
Apr-22-19 08:00AM	Can The Stock Market Keep Rising After A Strong First Quarter? (Investor's Business Daily)
Apr-19-19 08:02AM	Health-care drama has now spread to biopharma stocks (MarketWatch)
Apr-09-19 02:14PM	4 ETFs to Consider with Big Pharma on the Senates Hot Seat (ETF Trends)
Apr-03-19 12:23PM	Democrats, Republicans agree on legislation targeting drug prices (MarketWatch)
Mar-01-19 08:00AM	Why These Pharma ETFs Rallied on Thursday (Zacks)
Feb-28-19 04:43PM	Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results (ETF Trends)
Feb-15-19 02:16PM	Medicare would cover CAR-T therapies under new CMS proposal (MarketWatch)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-29-19 07:29AM	Biogen stock up 3% after 4Q earnings beat (MarketWatch)
Jan-23-19 11:33AM	BMO downgrades Merck to market perform (MarketWatch)
Jan-06-19 09:32AM	Outlook For Battered Biotech Stocks In 2019 (Investopedia)
Dec-31-18 02:30PM	4 Top-Ranked Undervalued Sector ETFs to Buy in 2019 (Zacks)
Dec-21-18 12:55PM	Perrigo stock plunges toward biggest drop in 24 years after disclosing $1.9 billion Irish back-tax bill (MarketWatch)
Dec-17-18 12:25PM	7 Major Pharmaceutical Stocks to Quarantine Now (InvestorPlace)
Dec-14-18 09:55AM	5 Incredible ETFs & Stocks to Buy on the Dip (Zacks)
Nov-19-18 01:25PM	Yahoo Finance Live: The Final Round - Nov 19th, 2018 (Yahoo Finance Video)
Nov-12-18 03:46PM	5 Stocks to Sell After the Midterm Election (InvestorPlace)
Nov-08-18 01:00PM	Midterms Produce Split Congress: ETF Areas in Focus (Zacks)
Nov-07-18 04:28PM	Here are the stock-market sectors in the spotlight after midterm elections (MarketWatch)
Oct-29-18 08:50AM	Elections Could Affect These Health Care ETFs (Investopedia)
Oct-25-18 10:39AM	With Midterms Looming, Consider Healthcare ETFs (ETF Trends)
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections (Zacks)
Oct-22-18 03:30PM	ETF Plays for a Divided Midterm Elections (ETF Trends)
Oct-15-18 12:41PM	Johnson & Johnson Stock Can Still Pick Up Speed, Analyst Says (Barrons.com)
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 (Investopedia)
Sep-24-18 09:52AM	Resurgent Pfizer Stock Testing 19-Year Resistance (Investopedia)
Sep-06-18 04:56PM	Pharmaceutical ETFs Could Maintain Their Momentum (ETF Trends)
Aug-13-18 04:07PM	Health Care ETFs Outperforming: Will the Rally Last? (Zacks)
Aug-02-18 07:29AM	5 Best-Performing Sector ETFs of July (InvestorPlace)
Jul-20-18 06:00AM	AbbVie Is the Next Great Drug Short: Citron (Investopedia)
Jul-19-18 10:14AM	AbbVie shares drop 5.5% after short seller Citron calls it 'next great drug short' (MarketWatch)
Jul-09-18 07:13AM	KemPharm's stock soars after ADHD drug trial meets primary endpoints (MarketWatch)
Jul-03-18 03:19PM	July Could Be a Volatile Month for Pharma ETFs (ETF Trends)
Jun-08-18 01:19PM	Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems (InvestorPlace)
Jun-04-18 11:01AM	Cramer: Pharmaceutical stocks are underperforming 'like nothing I've ever seen' (CNBC)
10:30AM	Cramer: Drug stocks are underperforming 'like nothing I'v... (CNBC Videos)
May-14-18 08:41AM	President Trumps big drug price speech boosts pharma stocks (MarketWatch)
Apr-02-18 12:12PM	Antibiotics Could Clean Up as M&A Catalyst (Barrons.com)
Mar-12-18 12:16PM	Pharmaceutical ETF Surges on Healthy Outlook (ETF Trends)
Feb-01-18 07:29AM	Pharmaceutical stocks drop after drug price mention in Trumps State of the Union (MarketWatch)
Jan-30-18 10:29AM	Health-care ETFs in focus on JP Morgan-Berkshire-Amazon d... (CNBC Videos)
Jan-25-18 11:10AM	Pfizer: Revenue Growth Is Expected in 4Q17 (Market Realist)
Jan-23-18 01:52PM	Mylan CEO: I'm excited about our pipeline (Yahoo Finance Video)
Jan-22-18 09:01AM	Merck & Co.s Animal Health Business in 3Q17 (Market Realist)
Jan-19-18 09:35AM	Johnson & Johnsons Revenue Estimates for 4Q17 (Market Realist)
Jan-18-18 10:47AM	Maybe High Drug Prices Are a Problem After All (Barrons.com)
Jan-17-18 04:35PM	Supernus Pharmaceuticals Stock Is an Institutional Favorite (Investopedia)
Jan-11-18 12:58PM	Is Valeant Pharmaceuticals Intl Inc a Buy? 3 Pros, 3 Cons (InvestorPlace)
10:32AM	Recent Developments for Mylan (Market Realist)
Jan-10-18 05:59PM	Corcept Therapeutics Stock Has Healthy Institutional Support (Investopedia)
Dec-28-17 10:31AM	Countdown to 2018: Merck Can Rise From the Muck (Barrons.com)
Nov-20-17 07:05AM	The FDA is cracking down on controversial supplement kratom (MarketWatch)
Nov-06-17 12:00PM	Pharmaceuticals Should Be Easy Pill to Swallow for 2018 Trump Trade (TheStreet.com)
Oct-26-17 02:11PM	EarningsWatch: Celgene tanks and Twitter spikes ahead of Amazon, Alphabet reports (MarketWatch)
Oct-24-17 06:06PM	Mercks 3Q17 Revenues Could Rise (Market Realist)
Oct-17-17 10:26AM	Neothetics's stock rockets on heavy volume after merger deal (MarketWatch)
Oct-16-17 12:33PM	President Trump reiterates that drug companies 'getting away with murder' but says not much else (MarketWatch)
Sep-20-17 11:47AM	Jump In Pet Adoptions Is Good News For Animal Health Stocks (Barrons.com)
Sep-19-17 05:09PM	ETF Flopper: Repeal and Replace Revived, Sinks Health-Care Stocks (Barrons.com)
Sep-11-17 07:36AM	Introducing Mercks 2Q17 Immuno-Oncology Blockbuster (Market Realist)
Sep-04-17 10:36AM	Eli Lillys Cardiovascular Products in 2Q17 (Market Realist)
Aug-30-17 10:37AM	Performance of Bristol-Myers Squibbs Eliquis in 2Q17 (Market Realist)
Aug-23-17 09:08AM	Defitelio Continues to Demonstrate Robust Demand Trends in 2017 (Market Realist)
Aug-21-17 02:36PM	Why Jazz Is Expected to Report a Robust Revenue Growth Rate (Market Realist)
Aug-11-17 08:42AM	Peregrine Pharmaceuticals laid off one-fifth of its workforce (MarketWatch)

SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

open in yahoo | open in marketwatch | open in google

XPH

SPDR Pharmaceuticals ETF

Upgrade your FINVIZ experience